美国德州大学安德森癌症中心转化基因组学与癌症精确医学博士后招聘

　　美国德州大学安德森癌症中心转化基因组学与癌症精确医学博士后招聘

　　Job Description

　　ELIGIBILITY REQUIREMENTS: Postdoctoral fellows must be U.S. citizens or have permanent residence. The current Predoctoral fellows positions associated with the T32 have no U.S. citizenship required.

　　The NCI T32 in Translational Genomics and Precision Medicine in Cancer (TGP) training program invites applicants for its postdoctoral and predoctoral training program at the University of Texas MD Anderson Cancer Center. The T32 program was developed in response to a new revolution of Big Data and the need for scientists to be trained in the discovery, integration and interpretation of translational genomics for precision medicine. The training plan allows qualified predoctoral or postdoctoral candidates to be educated and trained in-depth and breadth in state-of-the-art areas of translational genomics and precision medicine related to cancer. The goal is to educate and train the next generation of scientists to understand broadly their role in driving precision medicine through discovery science and development of novel genomic analytical tools necessary to power this application in the clinical setting. In addition to a mentored research experience by one of our outstanding training faculty, both PhD candidates and postdoctoral fellows are expected to gain interdisciplinary training in core competency areas critical to the future of translational genomic science.

　　Core Competencies for the program include a depth and breadth of knowledge in 5 areas: 1) translational cancer research, to gain exposure to mechanistic studies in translational research and their importance to the human organism; 2) precision medicine to gain experience in state-of-the-art ways to diagnose and target treatment of cancer patients based on genomic or immunogenetic profiles; 3) translational genetics and genomics, to gain competency in translational genomics needed for future understanding and implementation of cancer precision medicine; 4) bioinformatics, to learn how to read and interpret large omics datasets; and, 5) exposure to relevant tumor boards (monthly) and to industrial collaborations with academic faculty mentors on large scale genomic applications in cancer precision medicine.

　　T32 Departments & Faculty Mentors:

　　Translational Molecular

　　Pathology

　　• Krishna Bhat, PhD

　　• Ann Killary, PhD

　　• Larry Kwong PhD

　　• Sue-Hwa Lin, PhD

　　• Sendurai Mani, PhD

　　• Subrata Sen, PhD

　　• Rama Soundararajan, PhD

　　• Ignacio Wistuba, MD

　　Clinical Cancer Prevention

　　• Florencia McAllister, MD

　　• Eduardo Vilar-Sanchez, MD

　　Epidemiology

　　• Paul Scheet, PhD

　　GI Medical Oncology

　　• Scott Kopetz, MD, PhD

　　Genetics

　　• Nick Navin, PhD

　　• Ralf Krahe, PhD

　　• Sadhan Majumder, PhD

　　Melanoma Medical Oncology

　　• Chantale Bernatchez, PhD

　　Hematopathology and Pathology

　　• Timothy McDonnell, MD, PhD

　　• Anirban Maitra, MD, MBBS

　　Encouraging Diversity. The training program is committed to ensuring diversity in selecting outstanding fellows for the program. Minority, disadvantaged or disabled applicants are encouraged to apply.

　　For more information please contact the T32 Leadership Team:

　　Dr. Ann Killary, Ph.D., Professor, Translational Molecular Pathology, akillary@mdanderson.org

　　Dr. Ignacio Wistuba, M.D., Chair, Translational Molecular Pathology, iiwistuba@mdanderson.org

　　Jeannette McGee, Education Program Coordinator, Translational Molecular Pathology, JMcGee@mdanderson.org